Tenax Therapeutics (TENX) Net Cash Flow (2016 - 2017)
Historic Net Cash Flow for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to -$159073.0.
- Tenax Therapeutics' Net Cash Flow fell 10169.7% to -$159073.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$8.4 million, marking a year-over-year decrease of 23038.51%. This contributed to the annual value of $85.1 million for FY2024, which is 100927.23% up from last year.
- Per Tenax Therapeutics' latest filing, its Net Cash Flow stood at -$159073.0 for Q4 2017, which was down 10169.7% from -$469803.0 recorded in Q3 2017.
- Tenax Therapeutics' Net Cash Flow's 5-year high stood at $9.4 million during Q4 2016, with a 5-year trough of -$36.4 million in Q3 2014.
- In the last 5 years, Tenax Therapeutics' Net Cash Flow had a median value of -$469803.0 in 2017 and averaged -$2.3 million.
- Its Net Cash Flow has fluctuated over the past 5 years, first plummeted by 120541.88% in 2014, then surged by 945898.86% in 2016.
- Quarter analysis of 5 years shows Tenax Therapeutics' Net Cash Flow stood at $2.5 million in 2013, then plummeted by 398.93% to -$7.6 million in 2014, then skyrocketed by 98.68% to -$100160.0 in 2015, then skyrocketed by 9458.99% to $9.4 million in 2016, then plummeted by 101.7% to -$159073.0 in 2017.
- Its Net Cash Flow was -$159073.0 in Q4 2017, compared to -$469803.0 in Q3 2017 and -$4.8 million in Q2 2017.